RALEIGH, N.C., Oct. 07, 2022 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its third quarter earnings release after the market closes on November 1, 2022. Enact will host a conference call to review third quarter 2022 financial results on November 2, 2022 at 8:00 a.m. (ET).
Enact’s earnings release, summary presentation and financial supplement will be available through the company’s website, https://ir.enactmi.com/, at the time of their release to the public.
Enact’s conference call can be accessed via telephone and Internet. The dial-in number for Enact’s November 2nd conference call is 833-634-2594 or 412-902-4104 (outside the U.S.); participants should ask to be joined into the Enact Holdings, Inc. call. To participate in the call by webcast, register at https://ir.enactmi.com/news-and-events/events at least 15 minutes prior to the webcast to download and install any necessary software.
The webcast also will be archived on the company’s website for one year.
About Enact Holdings, Inc.
Enact (Nasdaq: ACT), operating principally through its wholly-owned subsidiary Enact Mortgage Insurance Corporation since 1981, is a leading U.S. private mortgage insurance provider committed to helping more people achieve the dream of homeownership. Building on a deep understanding of lenders’ businesses and a legacy of financial strength, we partner with lenders to bring best-in class service, leading underwriting expertise, and extensive risk and capital management to the mortgage process, helping to put more people in homes and keep them there. By empowering customers and their borrowers, Enact seeks to positively impact the lives of those in the communities in which it serves in a sustainable way. Enact is headquartered in Raleigh, North Carolina.
CONTACT: Investor Contact Daniel Kohl EnactIR@enactmi.com Media Contact Brittany Harris-Flowers email@example.com
- LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences - December 6, 2023
- Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City - December 6, 2023
- Alico, Inc. Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2023 - December 6, 2023